No-Cost, No-Obligation Ethicon Physiomesh Attorney Case Review

Ethicon Physiomesh Attorney
Ethicon Physiomesh Lawsuit News

Open Hernia Repair Techniques Versus Laparoscopy

Natural tissue open hernia repair outcomes produce a better result than laparoscopic techniques when all factors are taken into consideration

Thursday, August 15, 2019 - Experts continually debate if using hernia repair mesh is preferable to open hernia repair techniques and have found that in the short-term, hernia repair mesh using laparoscopic techniques may have an advantage. The reason for this is because the laparoscopic surgical site is much smaller and heals faster, therefore, recovery time is reduced. The short term hernia repair mesh advantage is more than offset, however, by the almost 300% greater rate of occurrences of major complications such as bowel injuries that laparoscopy and hernia mesh cause. Laparoscopic hernia mesh repair also had a 3 times greater rate of recurrences within five years. The study also debunked claims of less frequent hernia occurrences when using laparoscopic hernia repair. As a result of the study, many surgeons are finding that the short-term only benefits of hernia repair mesh are not worth the short-term risks when considering the disastrous complications that are possible including organ injury from doctors untrained in laparoscopic technique, bowel obstruction, and the fact that the procedure is more expensive. Ethicon Physiomesh lawsuits are represented by top national attorneys with have vast experience and offer a free consultation.

The study's conclusion also points out that laparoscopic hernia mesh repair surgery is not truly minimally invasive, merely minimal access surgery. With laparoscopy, major surgery is done on the organs and tissues that underlay the skin. Finally, the study summarizes that the benefits of laparoscopy, less post-operative pain and faster return to normal activities were more than offset by the cons of laparoscopic hernia repair being a higher risk of complications and increased cost. The study found that the rate of reoccurrence in a sample of Florida hernia repair outpatients was almost 20%.

According to the FDA, it was the high rate of hernia reoccurrence using open techniques that fueled the demand for hernia repair mesh. Doctors that use hernia repair mesh claim that the rate of reoccurrence drops by more than half when hernia repair mesh is used. The FDA cited the extreme adverse side effects that hernia repair mesh causes as being "pain, infection, hernia recurrence, scar-like tissue that sticks tissues together (adhesion), blockage of the large or small intestine (obstruction), bleeding, abnormal connection between organs, vessels, or intestines (fistula), fluid build-up at the surgical site (seroma), and a hole in neighboring tissues or organs (perforation)," with "pain, infection, hernia recurrence, adhesion, and bowel obstruction" being the most common. These symptoms have caused patients to seek hernia mesh removal which can be complicated and involve major surgery. It may be a sign that the device has broken free and perforated another organ if a patient is experiencing pain in a different part of the abdomen other than the site of the original hernia.

The magnitude of the potential number of hernia mesh lawsuits could be staggering. More than 20 million people per year worldwide have inguinal hernia repair surgery making it one of the more heavily performed, and profitable surgical procedures. Almost one in two men worldwide will suffer some form of inguinal hernia. About 10-12 percent of inguinal hernia repair surgeries eventually require a second surgery.

The entire presentation of the study summarized above, and much more, can be found at The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Youtube page located at

More Recent Ethicon Physiomesh Lawsuit News:

Lawyers for Ethicon Physiomesh Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. OnderLaw has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.